Highlighting technological advances for cancer research at AACR 2015
PHILADELPHIA--(BUSINESS WIRE), April 20, 2015 –Thermo Fisher Scientific, the world leader in serving science, today unveiled new innovations for research aimed at addressing the growing need for early detection, better prognosis, and more effective cancer treatments in the future. These new products and presentations are being featured at the American Association for Cancer Research (AACR) 2015 Annual Meeting, booth #1501 at the Pennsylvania Convention Center in Philadelphia, Pa.
Among Thermo Fisher's featured new products is Cynvenio's LiquidBiopsy platform:
- The automated Cynvenio LiquidBiopsy Instrument is designed to extract and isolate circulating tumor cells (CTCs) efficiently from a standard blood draw in preparation for both high content imaging and genomic analysis. The addition of Cynvenio’s rare cell enrichment technology complements the Ion PGM workflow to provide a comprehensive sample-to-genomic data research solution for analysis of CTCs, cell-free DNA (cfDNA) and normal DNA in less than 48 hours.
For more information on Thermo Fisher’s poster presentations and the new products being featured at AACR 2015, please visit here.